Total Holdings
60
Portfolio diversification across 60 positions
CANC
(NASDAQ)Tema Oncology ETF
$41.44-- (--)
Loading... - Market loading
CANC ETF Holdings: Tema Oncology ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$178.42M
Total fund assets
Expense Ratio
0.75%
Annual management fee
Fund Issuer
Tema
Nasdaq Stock Market
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Revolution Medicines, Inc | Stock | 7.18% |
| 2 |  | Eli Lilly and Company | Stock | 5.33% |
| 3 |  | Legend Biotech Corporation | Stock | 4.67% |
| 4 | S SWX:NOVN | Novartis AG | Stock | 4.43% |
| 5 |  | Cogent Biosciences, Inc. | Stock | 4.30% |
| 6 | O OTC:RHHBY | Roche Holding AG | Stock | 4.22% |
| 7 |  | Immunome, Inc | Stock | 4.18% |
| 8 | O OTCQX:RHHBY | Roche Holding AG | Stock | 4.16% |
| 9 | L LSE:AZN | AstraZeneca PLC | Stock | 3.67% |
| 10 |  | Merck & Co., Inc. | Stock | 3.56% |
| 11 |  | Bristol-Myers Squibb Company | Stock | 3.55% |
| 12 |  | Nuvalent, Inc. | Stock | 3.37% |
| 13 |  | Celcuity LLC | Stock | 3.22% |
| 14 | L LON:AZN | AstraZeneca PLC | Stock | 3.22% |
| 15 |  | Johnson & Johnson | Stock | 3.12% |
| 16 |  | Exelixis, Inc. | Stock | 3.00% |
| 17 |  | AbbVie Inc. | Stock | 2.94% |
| 18 |  | BridgeBio Pharma, Inc. | Stock | 2.91% |
| 19 |  | Genmab A/S | Stock | 2.83% |
| 20 |  | Amgen Inc. | Stock | 2.76% |
| 21 |  | Zai Lab Limited | Stock | 2.56% |
| 22 |  | CG Oncology, Inc. Common stock | Stock | 2.54% |
| 23 |  | IDEAYA Biosciences, Inc. | Stock | 2.40% |
| 24 | B BGNE | BeiGene, Ltd | Stock | 1.96% |
| 25 |  | BeOne Medicines AG | Stock | 1.80% |
| 26 |  | Enliven Therapeutics, Inc. | Stock | 1.50% |
| 27 |  | Summit Therapeutics PLC | Stock | 1.50% |
| 28 |  | Zymeworks Inc. | Stock | 1.44% |
| 29 |  | Relay Therapeutics, Inc. | Stock | 1.41% |
| 30 |  | Erasca Inc | Stock | 1.27% |
| 31 |  | Arcus Biosciences, Inc | Stock | 1.22% |
| 32 |  | Halozyme Therapeutics, Inc | Stock | 1.20% |
| 33 |  | AnaptysBio, Inc | Stock | 1.19% |
| 34 |  | Gilead Sciences, Inc | Stock | 1.11% |
| 35 |  | Immatics NV | Stock | 1.09% |
| 36 |  | Nuvation Bio Inc | Stock | 1.01% |
| 37 |  | UroGen Pharma Ltd | Stock | 1.01% |
| 38 |  | Corvus Pharmaceuticals Inc | Stock | 0.95% |
| 39 |  | Regeneron Pharmaceuticals, Inc | Stock | 0.87% |
| 40 |  | Inhibrx Inc | Stock | 0.76% |
| 41 | T TSE:4519 | Chugai Pharmaceutical Co. Ltd. | Stock | 0.71% |
| 42 |  | Guardant Health, Inc | Stock | 0.70% |
| 43 |  | Olema Pharmaceuticals Inc | Stock | 0.66% |
| 44 |  | Syndax Pharmaceuticals Inc | Stock | 0.63% |
| 45 |  | Natera, Inc | Stock | 0.59% |
| 46 |  | CytomX Therapeutics, Inc | Stock | 0.56% |
| 47 |  | Iovance Biotherapeutics, Inc | Stock | 0.54% |
| 48 |  | HUTCHMED (China) Limited | Stock | 0.53% |
| 49 |  | Immunocore Holdings plc | Stock | 0.50% |
| 50 |  | Arvinas, Inc | Stock | 0.48% |
Frequently Asked Questions About Tema Oncology ETF Holdings
What are the top holdings in CANC?
Tema Oncology ETF (CANC) holds 60 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.
How concentrated is CANC's portfolio?
Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review CANC's holdings table to analyze concentration risk.
What is CANC's sector allocation?
The Sector Allocation chart shows how CANC distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.
What countries does CANC invest in?
CANC's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.
How diversified is CANC ETF?
CANC's diversification can be assessed by reviewing its 60 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.